Clinical Trials Insight: 700019621
Phase of Trial: Phase I
Latest Information Update: 04 Dec 2007
At a glance
- Drugs Dronabinol (Primary)
- Indications Neuropathic pain; Pain
- Focus Adverse reactions; Pharmacokinetics
- Sponsors Cynapsus Therapeutics
- 04 Dec 2007 Status changed to completed according to Cannasat Therapeutics' media release.
- 27 Aug 2007 Status change from planning to initiated.
- 11 Dec 2006 New trial record.